Vince Owens, Founder and Managing General Partner of Guide Medical Ventures, has 25 years of medical device industry experience, including multiple successful exits as start-up founder and CEO. Most recently, he was co-founder and CEO of Intelect Medical, a deep brain stimulation technology company acquired by Boston Scientific in 2011. Mr. Owens holds a B.S. in Mechanical Engineering from Carnegie Mellon university and an MBA. Mr. Owens serves on the boards of several privately held medical device companies.
NATALIA TRAYANOVA, PhD
Chief Scientific Officer
Natalia Trayanova, PhD, FHRS, FAHA, Founder and CSO, is the Murray B. Sachs Professor of Biomedical Engineering, Johns Hopkins University, Baltimore, MD. Her current research interests include understanding the normal and pathological electromechanical behavior of the heart, with emphasis on translation of basic science mechanistic insight into the clinical practice. Specifically, her research focuses on the mechanisms for cardiac arrhythmogenesis and defibrillation, as well as on advancements in ventricular ablation and cardiac resynchronization therapy. Prof. Trayanova is the recipient of numerous awards, including the inaugural Marray B. Sachs Chair (2012) from Johns Hopkins University, Excellence in Research and Scholarship Award (2005) and the Outstanding Researcher Award (2002) from Tulane University, and the Fulbright Distinguished Research Award (2002). She was the Vice Chair (in 2007) and the Chair (in 2009) of the Gordon Research Conference on Cardiac Arrhythmia Mechanisms. She has authored or coauthored extensively, and has presented papers at a large number of international meetings.
BROCK TICE, PhD
Head of Technology
Brock Tice began his work on CardioSolv's technology in 2006 and has extensive experience in research and development of the company's patient-specific modeling and VT ablation guidance system. Dr. Tice received his PhD degree in Biomedical Engineering from Johns Hopkins University in 2009. Dr. Tice's doctoral research involved the creation and use of high-resolution computational models of the heart, with both structural and electrophysiological heterogeneities, and produced mechanistic insight into the initiation, sustenance, and termination of re-entrant arrhythmias.
STEVE GIROUARD, PhD
Steve Girouard was most recently President & CEO of Securus Medical, Inc (acquired by Boston Scientific). Prior to Securus he was Vice President of Emerging Technologies in the Corporate Office of Science and Technology at Johnson & Johnson. Earlier in his career he was a Partner at Omega Funds and Oakwood Medical Investors, and he was the founding Executive Director of the Cleveland Clinic Atrial Fibrillation Innovation Center, a center created for the development of novel technologies for the treatment of arrhythmias. He started his career at Guidant Corporation where he held various technology management positions. He holds over 35 United States and international patents and has authored numerous peer-reviewed articles and book chapters in the field of electrophysiology. Dr. Girouard earned his B.S. degree in Biomedical Engineering from Boston University and his Master’s and Doctoral degrees in Biomedical Engineering from Case Western Reserve University.
Chief Operating Officer
Scott Kokones, Founder and General Partner of Guide Medical Ventures, was cofounder and Sr. VP of R&D for Intelect Medical through successful exit in 2011. Prior to joining Intelect, Mr. Kokones held various R&D engineering and leadership roles at Medtronic and Enpath Medical, where he worked on implantable devices for SCS, CRDM, and DBS. He holds a B.S. in Mechanical Engineering from the University of Michigan and an MBA from Boston University. Mr. Kokones currently serves on the boards of several privately held companies.